The U.S. market has emerged as the preferred launch site for new medical technology as FDA regulations prioritize developers and innovation, according to a survey conducted by Boston Consulting Group and UCLA Biodesign released in March.
Read the full post on Becker's Hospital Review - Healthcare News
